{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:44:47Z","timestamp":1748972687623},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,9,14]],"date-time":"2005-09-14T00:00:00Z","timestamp":1126656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00213-005-0145-x","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T15:03:05Z","timestamp":1129906985000},"page":"1-12","source":"Crossref","is-referenced-by-count":28,"title":["Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72\u00a0h"],"prefix":"10.1007","volume":"183","author":[{"given":"Vincenzo","family":"Teneggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Tiffany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Squassante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Milleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Ziviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Bye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,9,14]]},"reference":[{"issue":"4","key":"145_CR1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/jama.288.4.468","volume":"288","author":"JS Ahluwalia","year":"2002","unstructured":"Ahluwalia JS, Harris KJ, Catley D, Okuyemi S, Mayo MS (2002) Sustained release bupropion for smoking cessation in African Americans. A randomise controlled trial. JAMA 288(4):467\u2013474","journal-title":"JAMA"},{"key":"145_CR2","first-page":"244","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatry Association","year":"1994","unstructured":"American Psychiatry Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatry Association, Washington, DC, p 244","edition":"4"},{"key":"145_CR3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1360-0443.1994.tb03738.x","volume":"89","author":"DJK Balfour","year":"1994","unstructured":"Balfour DJK (1994) Neuronal mechanisms underlying nicotine dependence. Addiction 89:1419\u20131423","journal-title":"Addiction"},{"key":"145_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00003495-199345020-00001","volume":"45","author":"NL Benowitz","year":"1993","unstructured":"Benowitz NL (1993) Nicotine replacement therapy: what has been accomplished\u2014can we do better? Drugs 45:157\u2013170","journal-title":"Drugs"},{"key":"145_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0306-4603(90)90013-N","volume":"15","author":"TH Brandon","year":"1990","unstructured":"Brandon TH, Tiffany ST, Obremski KM, Baker TB (1990) Post-cessation cigarette use: the process of relapse. Addict Behav 15:105\u2013114","journal-title":"Addict Behav"},{"key":"145_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1176\/ajp.149.4.464","volume":"149","author":"N Breslau","year":"1992","unstructured":"Breslau N, Kilbey MM, Andreski P (1992) Nicotine withdrawal symptoms and psychiatric disorders: finding from epidemiologic studies. Am J Psychiatry 149:464\u2013469","journal-title":"Am J Psychiatry"},{"key":"145_CR7","first-page":"25","volume-title":"Statistical power analyses for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analyses for the behavioral sciences, 2nd edn. Lawrence Erlbaum, Hillsdale, NJ, pp 25\u201326","edition":"2"},{"issue":"1","key":"145_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J (1992) A power primer. Psychol Bulletin 112(1):155\u2013159","journal-title":"Psychol Bulletin"},{"key":"145_CR9","volume-title":"Applied multiple regression\/correlation analyses for the behavioral sciences","author":"J Cohen","year":"1975","unstructured":"Cohen J, Cohen P (1975) Applied multiple regression\/correlation analyses for the behavioral sciences. Lawence Erlbaum, Hillsdale, NJ"},{"issue":"2","key":"145_CR10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1994.43","volume":"11","author":"BR Cooper","year":"1994","unstructured":"Cooper BR, Wang CM, Cox RF, Norton R, Shea V, Ferris RM (1994) Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology 11(2):133\u2013141","journal-title":"Neuropsychopharmacology"},{"key":"145_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02245149","volume":"107","author":"WA Corrigal","year":"1992","unstructured":"Corrigal WA, Franklin KB, Coen KM, Clark PBS (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107:285\u2013289","journal-title":"Psychopharmacology"},{"key":"145_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","volume":"3","author":"LS Cox","year":"2001","unstructured":"Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-Brief) in laboratory and clinical settings. Nicotine Tob Res 3:7\u201316","journal-title":"Nicotine Tob Res"},{"key":"145_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.pu.15.050194.002021","volume":"15","author":"SJ Curry","year":"1994","unstructured":"Curry SJ, Mc Bride CM (1994) Relapse prevention for smoking cessation. Review and evaluation of concepts and interventions. Annu Rev Public Health 15:345\u2013366","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"145_CR14","first-page":"55","volume":"6","author":"OJ Dalsgra\u00f0","year":"2004","unstructured":"Dalsgra\u00f0 OJ, Hansen NC, S\u00f8es-Petersen U, Evald T, H\u00f8egholm A, Barber J, Vestbo J (2004) A multicenter, randomised, double-blind, placebo controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees. Nicotine Tob Res 6(1):55\u201361","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"145_CR15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s002130000526","volume":"152","author":"GM Davies","year":"2000","unstructured":"Davies GM, Willner P, Morgan MJ (2000) Smoking related cues elicit craving in tobacco chippers: a replication and validation of the two-factor structure of the Questionnaire of Smoking Urge. Psychopharmacology 152(3):334\u2013342","journal-title":"Psychopharmacology"},{"key":"145_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(00)00122-9","volume":"393","author":"G Chiara Di","year":"2000","unstructured":"Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295\u2013314","journal-title":"Eur J Pharmacol"},{"key":"145_CR17","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Chiara Di","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Drug abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274\u20135278","journal-title":"Proc Natl Acad Sci U S A"},{"key":"145_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s002130000665","volume":"155","author":"J Dong","year":"2001","unstructured":"Dong J, Blier P (2001) Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology 155:52\u201357","journal-title":"Psychopharmacology"},{"issue":"4","key":"145_CR19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0149-2918(02)85130-X","volume":"24","author":"MJ Durcan","year":"2002","unstructured":"Durcan MJ, Deener G, White J, Johnston JA, Gonzales D, Niaura R, Rigotti N, Sachs DPL (2002) The effect of bupropion sustained release on cigarette craving after smoking cessation. Clin Ther 24(4):540\u2013551","journal-title":"Clin Ther"},{"key":"145_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0306-4603(78)90024-2","volume":"3","author":"KO Fagerstr\u00f6m","year":"1978","unstructured":"Fagerstr\u00f6m KO (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualisation of treatment. Addict Behav 3:235\u2013241","journal-title":"Addict Behav"},{"key":"145_CR21","first-page":"2","volume":"11","author":"RM Ferris","year":"1993","unstructured":"Ferris RM, Cooper BR (1993) Mechanism of antidepressant activity of bupropion. J Clin Psychiatry Monogr 11:2\u201314","journal-title":"J Clin Psychiatry Monogr"},{"key":"145_CR22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0095-4543(05)70122-6","volume":"26","author":"LH Ferry","year":"1999","unstructured":"Ferry LH (1999) Non-nicotine pharmacotherapy for smoking cessation. Prim Care 26:653\u2013669","journal-title":"Prim Care"},{"key":"145_CR23","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1001\/jama.1994.03510480064036","volume":"271","author":"MC Fiore","year":"1994","unstructured":"Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patches for smoking cessation: a meta-analysis. JAMA 271:1940\u20131947","journal-title":"JAMA"},{"key":"145_CR24","volume-title":"Treating tobacco use and dependence. Clinical practice guideline","author":"MC Fiore","year":"2000","unstructured":"Fiore MC, Bailey WC, Cohen SJ et al (2000) Treating tobacco use and dependence. Clinical practice guideline. US Department of Health and Human Services Public Health Service, Rockville, MD"},{"key":"145_CR25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-3223(02)01339-2","volume":"52","author":"TP George","year":"2002","unstructured":"George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR (2002) A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 52:53\u201361","journal-title":"Biol Psychiatry"},{"key":"145_CR26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1176\/ajp.150.4.546","volume":"150","author":"AH Glassman","year":"1993","unstructured":"Glassman AH (1993) Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 150:546\u2013553","journal-title":"Am J Psychiatry"},{"issue":"12","key":"145_CR27","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1055-9965.2012.13.12","volume":"13","author":"SS Gorin","year":"2004","unstructured":"Gorin SS, Heck JE (2004) Meta-analysis of the efficacy of tobacco counselling by health care providers. Cancer Epidemiol Biomarkers Prev 13(12):2012\u20132022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"145_CR28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1360-0443.1991.tb02629.x","volume":"86","author":"ER Gritz","year":"1991","unstructured":"Gritz ER, Carr CR, Marcus AC (1991) The tobacco withdrawal syndrome in unaided quitters. Br J Addict 86:57\u201369","journal-title":"Br J Addict"},{"key":"145_CR29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1749-6632.1999.tb09392.x","volume":"881","author":"A Halaris","year":"1999","unstructured":"Halaris A, Zhu H, Feng Y, Piletz JE (1999) Plasma agmatine and platelet imidazoline receptors in depression. Ann N Y Acad Sci 881:445\u2013451","journal-title":"Ann N Y Acad Sci"},{"key":"145_CR30","volume-title":"Pathophysiology of tobacco dependence. Psychopharmacology: the fourth generation of progress","author":"JE Henningfield","year":"1995","unstructured":"Henningfield JE, Schuh LM, Jarvik ME (1995) Pathophysiology of tobacco dependence. Psychopharmacology: the fourth generation of progress. Raven, New York"},{"key":"145_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archinte.1992.00400140096021","volume":"152","author":"DE Hilleman","year":"1992","unstructured":"Hilleman DE, Mohiuddin SM, Del Core MC, Sketch H (1992) Effect of buspirone on withdrawal symptoms associated with smoking cessation. Arch Intern Med 152:350\u2013352","journal-title":"Arch Intern Med"},{"key":"145_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(98)00222-5","volume":"51","author":"WD Horst","year":"1998","unstructured":"Horst WD, Preskorn SH (1998) Mechanism of action and clinical characteristics of three atypical antidepressant: venlafaxine, nefazodone, bupropion. J Affect Disord 51:237\u2013254","journal-title":"J Affect Disord"},{"key":"145_CR33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3322\/canjclin.50.3.143","volume":"50","author":"JR Hughes","year":"2000","unstructured":"Hughes JR (2000) New treatments in smoking cessation. CA Cancer J Clin 50:143\u2013151","journal-title":"CA Cancer J Clin"},{"key":"145_CR34","first-page":"25","volume":"17","author":"JR Hughes","year":"1993","unstructured":"Hughes JR, Glasela M (1993) Transdermal nicotine for smoking cessation. Health Values 17:25\u201331","journal-title":"Health Values"},{"key":"145_CR35","first-page":"21","volume":"1","author":"JR Hughes","year":"1992","unstructured":"Hughes JR, Hatsukami DK (1992) The nicotine withdrawal syndrome: a brief review and update. Int J Smok Cessation 1:21\u201326","journal-title":"Int J Smok Cessation"},{"issue":"1","key":"145_CR36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00427428","volume":"83","author":"JR Hughes","year":"1984","unstructured":"Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology 83(1):82\u201387","journal-title":"Psychopharmacology"},{"key":"145_CR37","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archpsyc.1991.01810250054007","volume":"48","author":"JR Hughes","year":"1991","unstructured":"Hughes JR, Stevens WG, Skoog K, Keenan RM, Fenwick JW (1991) Symptoms of tobacco withdrawal. Arch Gen Psychiatry 48:52\u201359","journal-title":"Arch Gen Psychiatry"},{"key":"145_CR38","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1360-0443.1994.tb03744.x","volume":"89","author":"JR Hughes","year":"1994","unstructured":"Hughes JR, Higgins ST, Bickel WK (1994) Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89:1461\u20131470","journal-title":"Addiction"},{"key":"145_CR39","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","volume":"337","author":"RD Hurt","year":"1997","unstructured":"Hurt RD, Sachs DPL, Glover PN, Sullivan CR, Croghan IT, Sullivan PM (1997) A comparison of sustained release bupropion and placebo for smoking cessation. New Engl J Med 337:1195\u20131202","journal-title":"New Engl J Med"},{"issue":"5","key":"145_CR40","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0149-2918(01)80023-0","volume":"23","author":"BD Jamerson","year":"2001","unstructured":"Jamerson BD, Nides M, Jorenby DE, Danahue R, Garret P, Johnston JA, Fiore MC, Rennard SI, Leishow SJ (2001) Late term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy and placebo. Clin Ther 23(5):744\u2013752","journal-title":"Clin Ther"},{"key":"145_CR41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","volume":"340","author":"DE Jorenby","year":"1999","unstructured":"Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto JL, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685\u2013691","journal-title":"N Engl J Med"},{"key":"145_CR42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jama.1994.03510320029025","volume":"2718","author":"SL Kenford","year":"1994","unstructured":"Kenford SL, Fiore CM, Jorenby DE, Smith SS, Wetter D, Baker TB (1994) Predicting smoking cessation. Who will quit with and without nicotine patches. JAMA 2718:589\u2013594","journal-title":"JAMA"},{"issue":"2","key":"145_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/1064-1297.5.2.137","volume":"5","author":"JD Killen","year":"1997","unstructured":"Killen JD, Fortmann SP (1997) Craving is associated with smoking relapse. Finding from three prospective studies. Exp Clin Psychopharmacol 5(2):137\u2013142","journal-title":"Exp Clin Psychopharmacol"},{"key":"145_CR44","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02244308","volume":"105","author":"JD Killen","year":"1991","unstructured":"Killen JD, Fortmann SP, Newman B, Varady A (1991) Prospective study of factors influencing the development of craving associated with smoking cessation. Psychopharmacology 105:191\u2013196","journal-title":"Psychopharmacology"},{"issue":"1","key":"145_CR45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02246058","volume":"119","author":"RC Klesges","year":"1995","unstructured":"Klesges RC, Klesges LM, De Bon M, Shelton ML, Isbell TR, Klem M (1995) Effects of phenylpropanolamine on withdrawal symptoms. Psychopharmacology 119(1):85\u201391","journal-title":"Psychopharmacology"},{"key":"145_CR46","first-page":"171","volume":"909","author":"GF Koob","year":"2000","unstructured":"Koob GF (2000) Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 909:171\u2013185","journal-title":"Ann N Y Acad Sci"},{"key":"145_CR47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.euroneuro.2003.08.005","volume":"13","author":"GF Koob","year":"2003","unstructured":"Koob GF (2003) Neuroadaptive mechanisms of addiction: studies on extended amygdale. Eur Neuropsychopharmacol 13:442\u2013452","journal-title":"Eur Neuropsychopharmacol"},{"key":"145_CR48","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","volume":"504","author":"SM Learned-Coughlin","year":"2003","unstructured":"Learned-Coughlin SM, Bergstr\u00f6m M, Savitcheva I, Ascher J, Schmith VD, L\u00e5ngstrom B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 504:800\u2013805","journal-title":"Biol Psychiatry"},{"key":"145_CR49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1037\/1064-1297.5.1.54","volume":"5","author":"SJ Leischow","year":"1997","unstructured":"Leischow SJ, Valente SN, Hill AL, Otte PS, Aickin M, Holden T, Kligman E, Cook G (1997) Effects of nicotine dose and administration method on withdrawal symptoms and side effects during short-term smoking abstinence. Exp Clin Psychopharmacol 5:54\u201364","journal-title":"Exp Clin Psychopharmacol"},{"key":"145_CR50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","volume":"163","author":"JH Meyer","year":"2002","unstructured":"Meyer JH, Goudling VS, Wilson AA, Hussey D, Christensen BK, Houle S (2002) Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology 163:102\u2013105","journal-title":"Psychopharmacology"},{"key":"145_CR51","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0193-953X(18)30194-1","volume":"16","author":"NS Miller","year":"1993","unstructured":"Miller NS, Gold MS (1993) A hypothesis for a common neuromechanical basis for alcohol and drug disorders. Psychiatr Clin North Am 16:105\u2013117","journal-title":"Psychiatr Clin North Am"},{"key":"145_CR52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0741-8329(01)00144-6","volume":"24","author":"H Miyata","year":"2001","unstructured":"Miyata H, Yanagita T (2001) Neurobiological mechanisms of nicotine craving. Alcohol 24:87\u201393","journal-title":"Alcohol"},{"issue":"1","key":"145_CR53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0899-3289(96)90115-7","volume":"8","author":"CA Patten","year":"1996","unstructured":"Patten CA, Martin JE (1996a) Measuring tobacco withdrawal: a review of self-report questionnaires. J Subst Abuse 8(1):93\u2013113","journal-title":"J Subst Abuse"},{"issue":"30","key":"145_CR54","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF02883397","volume":"18","author":"CA Patten","year":"1996","unstructured":"Patten CA, Martin JE (1996b) Does nicotine withdrawal affect smoking cessation? Clinical and theoretical issues. Ann Behav Med 18(30):190\u2013200","journal-title":"Ann Behav Med"},{"key":"145_CR55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0272-5231(21)00820-0","volume":"12","author":"JO Prochaska","year":"1991","unstructured":"Prochaska JO, Goldstain MG (1991) Process of smoking cessations: implications for clinicians. Clin Chest Med 12:727\u2013735","journal-title":"Clin Chest Med"},{"key":"145_CR56","first-page":"834","volume-title":"11th mental measurements year book","author":"NG Schneider","year":"1994","unstructured":"Schneider NG (1994) Smoker Compliant Scale (SCS), revised 1984. In: Kramer JJ et al (eds) 11th mental measurements year book. Buros Institute of Mental Measurements, Lincoln, NE, p 834"},{"key":"145_CR57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00426399","volume":"82","author":"NG Schneider","year":"1984","unstructured":"Schneider NG, Jarvik ME (1984) Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology 82:143\u2013144","journal-title":"Psychopharmacology"},{"key":"145_CR58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0306-4603(84)90052-2","volume":"9","author":"NG Schneider","year":"1984","unstructured":"Schneider NG, Jarvik ME, Forsythe AB (1984) Nicotine vs placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 9:149\u2013156","journal-title":"Addict Behav"},{"issue":"5","key":"145_CR59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0009-9236(96)90153-8","volume":"60","author":"NG Schneider","year":"1996","unstructured":"Schneider NG, Olmsted RE, Steinberg C, Sloan K, Daims RM, Brown HV (1996) Efficacy of buspirone in smoking cessation: a placebo controlled trial. Clin Pharmacol Ther 60(5):568\u2013575","journal-title":"Clin Pharmacol Ther"},{"key":"145_CR60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1525-1497.2000.11198.x","volume":"15","author":"CN Sciamanna","year":"2000","unstructured":"Sciamanna CN, Hoch JS, Duke GC, Fogle MN, Ford DE (2000) Comparison of five measures of motivation to quit smoking among a sample of hospitalised smokers. J Gen Intern Med 15:16\u201323","journal-title":"J Gen Intern Med"},{"key":"145_CR61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00634151","volume":"30","author":"SM Shiffman","year":"1976","unstructured":"Shiffman SM, Jarvik ME (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 30:35\u201339","journal-title":"Psychopharmacology"},{"key":"145_CR62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s002130050022","volume":"148","author":"S Shiffman","year":"2000","unstructured":"Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwanltney CJ, Paty JA, Gnys M, Evoniuk G, De Veaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology 148:33\u201340","journal-title":"Psychopharmacology"},{"issue":"4","key":"145_CR63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/14622200410001734067","volume":"6","author":"SR Shiffman","year":"2004","unstructured":"Shiffman SR, West RJ, Gilbert DG (2004) Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res 6(4):599\u2013614","journal-title":"Nicotine Tob Res"},{"key":"145_CR64","volume-title":"The Cochrane library, issue 2","author":"C Silagy","year":"2004","unstructured":"Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2004) Nicotine replacement therapy for smoking cessation (Cochrane review). In: The Cochrane library, issue 2. Update Software, Oxford"},{"key":"145_CR65","first-page":"321","volume":"295","author":"JE Slemmer","year":"2000","unstructured":"Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295:321\u2013327","journal-title":"J Pharmacol Exp Ther"},{"key":"145_CR66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF02245088","volume":"117","author":"IP Stolerman","year":"1995","unstructured":"Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117:2\u201310","journal-title":"Psychopharmacology"},{"key":"145_CR67","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(00)04724-3","volume":"357","author":"DP Tashkin","year":"2001","unstructured":"Tashkin DP, Kanner R, Bailey W, Anderson P, Nides MA, Gonzales D, Dozier G, Patel MK, Jamerson BD (2001) Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 357:1571\u20131575","journal-title":"Lancet"},{"key":"145_CR68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-002-1176-1","volume":"164","author":"V Teneggi","year":"2002","unstructured":"Teneggi V, Tiffany ST, Squassante L, Milleri S, Ziviani L, Bye A (2002) Smokers deprived of cigarettes for 72 hours: effect of nicotine patches on craving and withdrawal. Psychopharmacology 164:177\u2013187","journal-title":"Psychopharmacology"},{"key":"145_CR69","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1001\/jama.1991.03470220049025","volume":"266","author":"The Transdermal Nicotine Study Group","year":"1991","unstructured":"The Transdermal Nicotine Study Group (1991) Transdermal nicotine for smoking cessation: six-week results from two multicenter controlled clinical trials. JAMA 266:3133\u20133138","journal-title":"JAMA"},{"key":"145_CR70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1037\/0022-006X.68.2.233","volume":"68","author":"ST Tiffany","year":"2000","unstructured":"Tiffany ST, Cox LS, Elash CA (2000) Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 68:233\u2013240","journal-title":"J Consult Clin Psychol"},{"key":"145_CR71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1365-2796.2003.01185.x","volume":"254","author":"P T\u00f8nnesen","year":"2003","unstructured":"T\u00f8nnesen P, Tonstad S, Hjalmason A, Lebargy F, Van Spiegel PI, Hider A, Sweet R, Townsend J (2003) A multicentre, randomised, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med 254:184\u2013192","journal-title":"J Intern Med"},{"key":"145_CR72","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","volume":"24","author":"S Tonstad","year":"2003","unstructured":"Tonstad S, Farsang C, Klaene G, Lewis K, Manolis AP, Perruchoud AP, Silagy C, van Spiegel PI, Astbury C, Hider A, Sweet R (2003) Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomized study. Eur Heart J 24:946\u2013955","journal-title":"Eur Heart J"},{"key":"145_CR73","unstructured":"UNDCP and WHO Informal Expert Committee on the Drug-Craving Mechanism (1992) Report, United Nations International Drug Control Program and World Health Organization Technical Report Series V:92\u201354439T"},{"key":"145_CR74","volume-title":"The health consequences of smoking: nicotine addiction, a report of surgeon general (DHHS publication N CDC 88-8406)","author":"US Department of Health and Human Services","year":"1988","unstructured":"US Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction, a report of surgeon general (DHHS publication N CDC 88-8406). US Government Printing Office, Washington, DC"},{"key":"145_CR75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/14622200050011277","volume":"2","author":"SS Watkins","year":"2000","unstructured":"Watkins SS, Koob GF, Markou A (2000) Neuronal mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal. Nicotine Tob Res 2:19\u201337","journal-title":"Nicotine Tob Res"},{"key":"145_CR76","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1360-0443.1992.tb02689.x","volume":"87","author":"R West","year":"1992","unstructured":"West R (1992) The nicotine replacement paradox in smoking cessation: how does nicotine gum really work? Br J Addict 87:165\u2013167","journal-title":"Br J Addict"},{"key":"145_CR77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02244560","volume":"104","author":"R West","year":"1991","unstructured":"West R, Hajek P, Mc Neill A (1991) Effect of buspirone on cigarette withdrawal symptoms and short term abstinence rate in a smokers clinic. Psychopharmacology 104:91\u201396","journal-title":"Psychopharmacology"},{"key":"145_CR78","volume-title":"Tobacco or health. A global status report","author":"World Health Organization","year":"1997","unstructured":"World Health Organization (1997) Tobacco or health. A global status report. WHO, Geneva, Switzerland"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0145-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-0145-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-0145-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T05:25:36Z","timestamp":1683264336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-0145-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,14]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["145"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-0145-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,14]]}}}